Open access
121
Views
13
CrossRef citations to date
0
Altmetric
Original Research
Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan
Kaoru Yamabe1 Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Nihonbashi, Chuouku, Tokyo 103-8668, Japan, [email protected]Correspondence[email protected]
, Ryan Liebert2 Health Outcomes Research, Kantar Health, New York, NY 10010, USA
, Natalia Flores2 Health Outcomes Research, Kantar Health, New York, NY 10010, USA
& Chris L Pashos3 Global Outcomes and Epidemiology Research, Data Sciences Institute, Takeda Pharmaceuticals International Inc., Cambridge, MA, 02139, USA
Pages 221-232
|
Published online: 12 Mar 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.